Cordiali-Fei, P <br/><br/>
Immunologic biomarkers for clinical and therapeutic management of psoriasis.  [electronic resource] 

 -  Mediators of inflammation  2014 
 - 236060 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1466-1861 
<br/><br/><label>Standard No.: </label>10.1155/2014/236060  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adult<br/>Anti-Inflammatory Agents--administration & dosage<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Biomarkers--blood<br/>Etanercept<br/>Female<br/>Humans<br/>Immunoglobulin G--administration & dosage<br/>Infliximab<br/>Interleukin-6--blood<br/>Interleukins--blood<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Psoriasis--blood<br/>Receptors, Tumor Necrosis Factor--administration & dosage<br/>T-Lymphocytes, Regulatory--metabolism<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Interleukin-22